POINT Biopharma Global (PNT)
US Market

POINT Biopharma Global (PNT) Stock Price & Analysis


PNT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$5.59 - $11.13
Previous Close$9.27
Average Volume (3M)687.75K
Market Cap
Enterprise Value$549.74M
Total Cash (Recent Filing)$430.03M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)11.1
Aug 11, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.84
Shares Outstanding105,693,356
10 Day Avg. Volume592,542
30 Day Avg. Volume687,747
Standard Deviation0.15
Financial Highlights & Ratios
Price to Book (P/B)2.08
Price to Sales (P/S)103.60
Price to Cash Flow (P/CF)-10.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.33
Enterprise Value/Gross Profit2.43
Enterprise Value/Ebitda4.73
Price Target Upside59.65% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was POINT Biopharma Global’s price range in the past 12 months?
POINT Biopharma Global lowest stock price was $5.59 and its highest was $11.13 in the past 12 months.
    What is POINT Biopharma Global’s market cap?
    Currently, no data Available
    When is POINT Biopharma Global’s upcoming earnings report date?
    POINT Biopharma Global’s upcoming earnings report date is Aug 11, 2023 which is in 69 days.
      How were POINT Biopharma Global’s earnings last quarter?
      POINT Biopharma Global released its earnings results on May 15, 2023. The company reported -$0.16 earnings per share for the quarter, beating the consensus estimate of -$0.316 by $0.156.
        Is POINT Biopharma Global overvalued?
        According to Wall Street analysts POINT Biopharma Global’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does POINT Biopharma Global pay dividends?
          POINT Biopharma Global does not currently pay dividends.
          What is POINT Biopharma Global’s EPS estimate?
          POINT Biopharma Global’s EPS estimate is -$0.31.
            How many shares outstanding does POINT Biopharma Global have?
            POINT Biopharma Global has 105,693,360 shares outstanding.
              What happened to POINT Biopharma Global’s price movement after its last earnings report?
              POINT Biopharma Global reported an EPS of -$0.16 in its last earnings report, beating expectations of -$0.316. Following the earnings report the stock price went up 9.833%.
                Which hedge fund is a major shareholder of POINT Biopharma Global?
                Among the largest hedge funds holding POINT Biopharma Global’s share is Baker Bros Advisors LP. It holds POINT Biopharma Global’s shares valued at 8M.


                  POINT Biopharma Global Stock Smart Score

                  The POINT Biopharma Global stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  POINT Biopharma Global

                  Therapeutics Acquisition Corp is a blank check company.


                  Top 5 ETFs holding PNT

                  Market Value
                  Smart Score
                  Vanguard Health Care ETF
                  iShares Core S&P Total U.S. Stock Market ETF
                  Fidelity MSCI Health Care Index ETF
                  iShares Russell 3000 ETF
                  Vanguard U.S. Momentum Factor ETF
                  Up to five ETFs with an Outperform Smart Score that hold PNT. The ETFs are listed according to market value of PNT within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Adicet Bio
                  PureTech Health
                  4D Molecular Therapeutics
                  CTI BioPharma

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis